Optimizing Tableting Processes with Quality by Design
A technical forum featuring Tim Freeman of Freeman Technology and Carl Levoguer of Malvern Instruments.
FDA Explores Options to Expand Access to Non-Rx Drugs
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
All Eyes Alert
It's better to catch costly mistakes in the laboratory before they reach the accounting department.
Facilitating Efficient Equipment Cleaning
Equipment design and cleaning procedures both play a role in thorough sterilization and cleaning.
Formulation Development Forum: Targeted Polymeric Nanoparticles
Targeted polymeric nanoparticles are an important vehicle for controlling and targeting dosing of chemotherapeutic agents.
Meeting Manufacturing Challenges Tied to Extended-Release Injectables
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.
FDA Perspectives: Scientific Considerations of Forced Degradation Studies in ANDA Submissions
The author outlines the scientific aspects of forced degradation studies that should be considered in relation to ANDA submissions.
Some Supply Chain Lessons Can Go a Long Way towards Success
Apple's experience with manufacturing facilities in China present opportunity for future best practice.
Channeling Steve Jobs
Service providers must focus on delivering a superior customer experience.
The Growing Orphan-Drug Paradigm
How niche strategies can offer mainstream potential for biopharmaceutical companies.
In the Spotlight May 2012
New product reviews for May 2012.
Optimizing Drug Delivery for Modern Biologics
The author discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.
Report from Poland
Poland's government aims to make the Eastern European country a biotech powerhouse.
Seeking Chemocatalytic and Biocatalytic Solutions
Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.
Tackling Global Health Concerns
Industry, the public sector, and individuals can play an important role in creating solutions.
Regulation and Compliance: 483 Responses
Q&A with David Elder of Strategic Compliance Consulting, PAREXEL International on responding to a 483 within 15 days. Elder is a former senior official with FDA.
Pharmaceutical Technology, May 2012 Issue (PDF)
Extended-Release Injectables
